{"entity":{"type":"insider","cik":"0001820187","url":"/insider/0001820187","json_url":"/insider/0001820187.json","name":"Walker Marlan D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2021-05-12","last":"2025-04-15","span_basis":"filed_date"},"name_variants":[{"name":"Walker Marlan D","source":"filing","n_filings":7,"first_seen":"2021-05-12","last_seen":"2025-04-15"}],"transactions":[{"id":4026840,"accession":"0000905148-25-001215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-001215","line_url":"/filing/0000905148-25-001215#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":490.0,"shares_display":"490","price_per_share":0.9985,"price_display":"1.00","price_state":"stated","total_value":489.265,"total_display":"489.26","total_whole":"489","shares_owned_after":73639.0,"shares_owned_after_display":"73,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-14","filed_date":"2025-04-15","scope":"insider"},{"id":4978049,"accession":"0000905148-25-001190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-25-001190","line_url":"/filing/0000905148-25-001190#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1167.0,"shares_display":"1,167","price_per_share":0.8572,"price_display":"0.86","price_state":"stated","total_value":1000.3524,"total_display":"1,000.35","total_whole":"1,000","shares_owned_after":73149.0,"shares_owned_after_display":"73,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-10","filed_date":"2025-04-10","scope":"insider"},{"id":4978042,"accession":"0000905148-25-001190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-001190","line_url":"/filing/0000905148-25-001190#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1136.0,"shares_display":"1,136","price_per_share":0.8747,"price_display":"0.87","price_state":"stated","total_value":993.6592,"total_display":"993.66","total_whole":"994","shares_owned_after":71982.0,"shares_owned_after_display":"71,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-10","scope":"insider"},{"id":8658845,"accession":"0001209191-23-057725","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-057725","line_url":"/filing/0001209191-23-057725#line-3","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4550.0,"shares_display":"4,550","price_per_share":2.239,"price_display":"2.24","price_state":"stated","total_value":10187.45,"total_display":"10,187.45","total_whole":"10,187","shares_owned_after":62565.0,"shares_owned_after_display":"62,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-07","scope":"insider"},{"id":8658842,"accession":"0001209191-23-057725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057725","line_url":"/filing/0001209191-23-057725#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":2.3101,"price_display":"2.31","price_state":"stated","total_value":33496.45,"total_display":"33,496.45","total_whole":"33,496","shares_owned_after":67115.0,"shares_owned_after_display":"67,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-07","scope":"insider"},{"id":9271987,"accession":"0001209191-23-027361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-027361","line_url":"/filing/0001209191-23-027361#line-1","is_derivative":false,"issuer_cik":"0001820187","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0001820187","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":692.0,"shares_display":"692","price_per_share":3.6381,"price_display":"3.64","price_state":"stated","total_value":2517.5652,"total_display":"2,517.57","total_whole":"2,518","shares_owned_after":11615.0,"shares_owned_after_display":"11,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-26","filed_date":"2023-05-04","scope":"insider"},{"id":8042311,"accession":"0001209191-23-024388","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-024388","line_url":"/filing/0001209191-23-024388#line-5","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1170.0,"shares_display":"1,170","price_per_share":3.6543,"price_display":"3.65","price_state":"stated","total_value":4275.531,"total_display":"4,275.53","total_whole":"4,276","shares_owned_after":12307.0,"shares_owned_after_display":"12,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider"},{"id":6466248,"accession":"0001209191-22-060587","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-060587","line_url":"/filing/0001209191-22-060587#line-4","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1048.0,"shares_display":"1,048","price_per_share":4.9475,"price_display":"4.95","price_state":"stated","total_value":5184.98,"total_display":"5,184.98","total_whole":"5,185","shares_owned_after":6685.0,"shares_owned_after_display":"6,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-09","scope":"insider"},{"id":5387991,"accession":"0001387131-21-005570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-21-005570","line_url":"/filing/0001387131-21-005570#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001820187","owner_name":"Walker Marlan D","owner_display_name":"Walker Marlan D","owner_url":"/insider/0001820187","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21592.0,"shares_display":"21,592","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":22455.68,"total_display":"22,455.68","total_whole":"22,456","shares_owned_after":28908.0,"shares_owned_after_display":"28,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Officer (Chief Executive Officer)","n_filings":7,"first_seen":"2021-05-12","last_seen":"2025-04-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001820187","retrieved_at":"2026-08-26T19:41:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}